Skip to main content
. 2018 Apr 27;9(32):22717–22726. doi: 10.18632/oncotarget.25216

Table 1. Area under the ROC curve (AUC), specificity and sensitivity of the best performing parenclitic and RDLG models for early (>34.5 months to diagnosis) and late (<14.5 months to diagnosis) groups.

Group Type Model AUC Specificity Sensitivity
Early Parenclitic -7.44 (Alpha-centrality) 0.624 1 0.189 ± 0.124
-0.16 (Pill use)
RDLG -2.09 (GPC1) 0.663 1 0.163 ± 0.087
Late Parenclitic 0.07 (Connections to MUC16) 0.904 1 0.803 ± 0.077
RDLG 2.14 (MUC16) 0.904 1 0.767 ± 0.082

Models were generated using all combinations of 1, 2 or 3 markers and following cross-validation the best models were selected based initially on sensitivity and secondly on AUC. Specificity was set to be >98% and the maximum is reported for the given sensitivity. Models were generated by logistic regression of either the parenclitic topologies or raw data and model coefficients are provided.